montacephalin(115995-12-5)
- Name: montacephalin
- Synonyms:2-Butenoicacid, 3-methyl-,2,3,3a,4,5,7,9a,9b-octahydro-4,9a-dihydroxy-6,9-dimethyl-3-methylene-2,7-dioxoazuleno[4,5-b]furan-5-ylester, [3aR-(3aa,4a,5b,9aa,9bb)]-; Azuleno[4,5-b]furan,2-butenoic acid deriv.; Montacephalin
- Molecular Formula:C20H22 O7
- Molecular Weight:374.38
- CAS Registry Number:115995-12-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 468-82-6/Labda-7-ene-15-oic acid
- 5679-16-3/N-[(1Z,3E)-1-{[(2E)-2-{[5-(4-bromophenyl)furan-2-yl]methylidene}hydrazino]carbonyl}-4-phenylbuta-1,3-dien-1-yl]benzamide
- 75219-48-6/2-{[(17beta)-3-(acetyloxy)estra-1,3,5(10)-trien-17-yl]oxy}-2-oxoethyl 4-{4-[bis(2-chloroethyl)amino]phenyl}butanoate
- 102489-56-5/2-({2-[(2-chloro-6-methylphenyl)amino]-2-oxoethyl}sulfanyl)-N,N-diethylethanaminium chloride
- 53316-58-8/6-amino-1,3,4-triphenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
- 94279-79-5/Glycerides, C16-18 and C16-18-unsatd. mono-
- 81975-90-8/3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 4-O-[3-O-acetyl-2,6-dideoxy-4-O-(6-methyl-5-oxotetrahydro-2H-pyran-2-yl)hexopyranosyl]-2,3,6-trideoxy-3-(dimethylamino)hexopyranoside
- 68990-22-7/2-chlorobutane
- 5900-03-8/2-({4-chloro-6-[4-(3,3-dimethylbutanoyl)-3-methylpiperazin-1-yl]pyrimidin-2-yl}sulfanyl)-N-(pyridin-3-ylmethyl)acetamide
- 94095-21-3/Formaldehyde, reaction products with sulfonated terphenyl, sodium salts
- 132490-64-3/frx B protein
- 5950-38-9/(4Z)-4-[(4-bromophenyl)(hydroxy)methylidene]-1-pyridin-2-yl-5-pyridin-3-ylpyrrolidine-2,3-dione
- 94158-50-6/1-[5-[[[(4-chlorophenyl)amino]carbonyl]amino]-o-tolyl]-3-(p-tolyl)urea
- 89427-27-0/5,7-dichloro-4,6-difluoro-2-(trifluoromethyl)-1H-benzimidazole
- 68951-86-0/Fatty acids, tall-oil, polymers with bisphenol A, epichlorohydrin, glycerol, pentaerythritol, phthalic anhydride and rosin
- 175524-68-2/Glucagon-like peptide 1 (Amphiuma tridactylum)
- 89796-85-0/1,1-bis(2-chloroethyl)-3-ethylthiourea
- 68441-66-7/Decanoic acid, mixed esters with dipentaerythritol, octanoic acid and valeric acid
- 70166-96-0/N-[(3-fluorophenyl)carbamoyl]-2-(4-hydroxy-4-phenylpiperidin-1-yl)acetamide
- 115995-12-5/montacephalin
- 68921-84-6/2-(Dimethylamino)benzoic acid 2-ethylhexyl ester
- 66564-24-7/2-Propen-1-ol, polymer with 2,2-(1,2-ethanediylbis(oxy))bis(ethanethiol), ethenyldiethoxymethylsiilane, alpha-hydro-omega-hydroxypoly(oxy-1,4-butanediyl) and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane
- 70632-01-8/4H-1-Benzopyran-4-one,6,6'-methylenebis[5,- 7-dihydroxy-2-(4-hydroxyphenyl)-
- 6215-63-0/(5E)-5-[4-(benzyloxy)-3-chloro-5-methoxybenzylidene]-3-phenyl-2-thioxo-1,3-thiazolidin-4-one
- 34926-25-5/3-chloro-4-isopropoxyphenylacetonitrile
- 21122-75-8/N-(2,4-dichlorophenyl)-2-{[3-(trifluoromethyl)phenyl]amino}benzamide
- 6306-59-8/N-methyl-3-(piperidin-1-yl)propan-1-amine
- 72843-38-0/1-Amino-1,4-dideoxy-2-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-β-L-lyxo-heptopyranosyl)-5-O-methyl-4-(methylamino)-D-myo-inositol
- 94246-75-0/Tripotassium (5-((4-amino-6-chloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((2-hydroxy-4-sulpho-1-naphthyl)azo)naphthalene-2,7-disulphonato(5-))cuprate(3-)
- 161897-62-7/3,8-Cyclotridecadien-1-one,7-hydroxy-13-(hydroxymethyl)-3,7,13-trimethyl-10-(1-methylethyl)-,(3E,7R,8E,10S,13S)-